Synopsis
HIV is associated with structural deficits
in the basal ganglia (BG). Volumes from structural MRI may relate to metabolic
changes measurable with magnetic resonance spectroscopy. We investigated the
relationship between BG NAA and Glutamate/Glutamine and caudate, putamen,
nucleus accumbens and subcortical gray matter (GM) volumes in 7-year old HIV-infected
children on antiretroviral therapy and uninfected controls. Higher NAA was
associated with smaller accumbens and left putamen in all children. Higher Glutamate/Glutamine
was associated with greater subcortical GM in controls, but not HIV-infected
children. Relationships between brain metabolites and volumes add to the
description of effects of HIV/ART on the BG.Purpose
HIV infection is associated with structural
deficits of the basal ganglia (BG). Volume deficits may be related to changes
in cerebral metabolites measured with MRS. Altered relationships between metabolite
levels and BG volumes may provide a clearer picture of the effects of HIV on
the brain than one measure alone. However, relationships between these measures
in healthy children are not known.
Previous studies in HIV-infected adults
have found lower BG N-acetyl-aspartate (NAA) to be associated with reduced temporal
lobe
(1), putamen, and thalamus volumes
(2). Lower Glutamate/Glutamine
(GluGln) has been associated with reduced cortical gray matter (GM), caudate
and thalamus volumes
(1), but also with increased putamen and thalamus
volumes
(2). Our aims were to investigate the relationship between
NAA/GluGln and BG volumes in healthy children and to determine whether these
relationships are altered in HIV-infected children on antiretroviral therapy
(ART).
Methods
Participants were 104 isiXhosa children
from a neuroimaging follow-on study of the Children with HIV Early
Antiretroviral Therapy (CHER) trial. All HIV-infected children had started ART
before 18 months of age and were stable on ART by the time of scanning at age 7.
Scanning was performed on a 3T Allegra (Siemens,
Erlangen, Germany). The protocol included a high-resolution T1-weighted 3D
EPI-navigated(3) multiecho magnetisation prepared rapid gradient
echo (MEMPRAGE)(4) (FOV 224 x 224 mm2, TR 2530 ms, TI
1160 ms, TE’s = 1.53/3.19/4.86/6.53 ms, bandwidth 650Hz/px, 144 sagittal slices,
1.3 x 1.0 x 1.0 mm3). Single voxel ¹H spectroscopy (SVS) in the BG was
obtained using an EPI volumetric navigated point-resolved spectroscopy (PRESS)
sequence with real-time first-order shim and motion correction(5) (TR
= 2000 ms, TE = 30 ms, 64 measurements, vector size 512, spectral bandwidth 1000
Hz). Water unsuppressed ¹H MRS measurements were acquired for water scaling and
eddy current correction. Scans were performed according to protocols approved
by the Human Research Ethics Committees of the Universities of Cape Town and Stellenbosch.
FreeSurfer version 5.1.0 was used to
perform automated segmentation of subcortical structures to generate regional
volume measures. LCModel(6) was used to calculate metabolite concentrations
from frequency and phase-corrected water-suppressed spectra using water scaling.
The SVS voxel was segmented using SPM12 to determine tissue type composition. SVS
data were not acquired for 9 children, and spectra from a further 32 were
excluded due to SNRs <7, leaving 63 children with both volume and SVS data
(38 HIV-infected, 25 controls, age 7.2 ± 0.16 years, 26 boys).
Statistical analysis was performed using R. Subcortical
GM, right and left caudate, putamen and nucleus accumbens volumes were
regressed against NAA and GluGln concentrations, testing for an interaction of
metabolite level with HIV infection status and accounting for age, gender and
intracranial volume. Group differences in metabolites and volumes between
HIV-infected children and controls were tested using ANCOVA controlling for the
confounders.
Results
In controls, NAA in BG was negatively
associated with volumes of the right (slope=-180,
p=0.008, figure 1) and left (slope=-143,
p=0.03, figure 2) nucleus accumbens and left putamen (slope= -727,
p=0.04). There was no significant interaction
of HIV status. GluGln related positively to subcortical GM volume in controls only (slope=380,
p=0.02), with a significant interaction effect of HIV status (
p=0.04, figure 3).
ANCOVAs controlling for age, gender and ICV
indicated smaller right (
p=0.01) and
left (
p=0.0008) nucleus accumbens,
lef t putamen (
p=0.009) and
subcortical GM (
p=0.01) in
HIV-infected children. Higher mean NAA and GluGln in the HIV-infected children than
controls was not significant (
p=0.9,
p=0.4 respectively).
Discussion
Increased NAA – a marker of neuronal health
– is associated with smaller volumes of nucleus accumbens and putamen in both
HIV-infected children and controls. This suggests that smaller volumes reflect
denser neuronal organization in both groups, consistent with previous studies
indicating that NAA gradually increases during childhood(7), while absolute
volumes of subcortical structures including nucleus accumbens decrease during
the same period(8). However, it does not explain why in our sample
the controls have larger nucleus accumbens and putamen volumes than
HIV-infected children, unless this is due to accelerated maturation in the
HIV-infected group that is only evident in the narrow age range of this sample.
The positive relationship of GluGln with subcortical GM volume seen in controls is not seen in HIV-infected children on ART, suggesting a possible effect of HIV/ART.
Conclusion
Measurement of metabolites as well as
volumes may provide a more complete – and more complex – description of the
effects of HIV/ART on the brain. Normal relationships between metabolites and
BG volumes should be established to determine when the breakdown of these
relationships may be an indicator of disease.
Acknowledgements
Support for this study was provided by NRF/DST South African Research Chairs Initiative; US National Institute of Allergy and Infectious Diseases (NIAID) through the CIPRA network, Grant U19 AI53217; NIH grants R01HD071664, R21MH096559 and R21MH10834601; NRF grant CPR20110614000019421, and the Medical Research Council (MRC). We thank the CUBIC radiographers (Marie-Louise de Villiers and Nailah Maroof), our research staff (Thandiwe Hamana and Rosy Khethelo), and Shabir A. Madhi for access to control participants on the CIPRA-SA04 trial.References
(1) Cohen
RA, et al. Cerebral metabolite abnormalities in human immunodeficiency virus
are associated with cortical and subcortical volumes. J Neurovirol. 2010;16(6):435-44.
(2) Hua X,
et al. Disrupted cerebral metabolite levels and lower nadir CD4 + counts
are linked to brain volume deficits in 210 HIV-infected patients on stable
treatment. Neuroimage
Clin. 2013; 3(3):132-42.
(3) Tisdall MD, Hess AT, et al. Volumetric
navigators for prospective motion correction and selective reacquisition in
neuroanatomical MRI. Magn Reson Med. 2012;68(2):389-99.
(4) van der Kouwe AJ, Benner T, Salat DH,
Fischl B. Brain morphometry with multiecho MPRAGE. Neuroimage. 2008 Apr
1;40(2):559-69.
(5) Hess AT, Tisdall MD, Andronesi OC,
Meintjes EM, van der Kouwe AJ. Real-time motion and B0 corrected single voxel
spectroscopy using volumetric navigators. Magn Reson Med. 2011;66(2):314-23
(6) Provencher SW. Estimation of metabolite
concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 1993;
30, 672–679.
(7) Blüml S, Wisnowski JL, et al. Metabolic
Maturation of the Human Brain From Birth Through Adolescence: Insights From In
Vivo Magnetic Resonance Spectroscopy. Cerebral Cortex.
2013;23:2944–2955
(8) Wierenga L,
Langen M et al. Typical development of basal ganglia, hippocampus, amygdala and
cerebellum from age 7 to 24. Neuroimage. 2014 Aug 1;96:67-72.